Bioequivalence tests getting stimulated

The Korea Food and Drug Administration said that average 10 items are under bioequivalence tests during this month and frequent enquires on these tests are being made from drug manufacturing firms, which is stimulated by the new government's strong policy to provide the incentives for bioequivalence-proven drugs.

So far, many pharmaceutical firms have been doubtful on the implementation of g...